Lastly, a 47-year-old female [73] was diagnosed with NPM1-mutated and FLT3 wild-type AML and treated with “7 + 3” cytarabine/anthracycline induction and four cycles of high-dose cytarabine consolidation, obtaining complete remission (CR). The gene discussed is FLT3; the disease is acute myeloid leukemia.